(1)
Commentary on “Preventive Percutaneous Coronary Intervention Versus Optimal Medical Therapy Alone for the Treatment of Vulnerable Atherosclerotic Coronary Plaques (PREVENT): A Multicenter, Open-Label, Randomized Controlled trial.”
Bleeding Thromb Vascul Biol 2024,
3 (2).
https://doi.org/10.4081/btvb.2024.141.